Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

ClinicalTrials.gov ID: NCT05432167

Public ClinicalTrials.gov record NCT05432167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 10:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension (uHTN) and Chronic Kidney Disease (CKD).

Study identification

NCT ID
NCT05432167
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
195 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2022
Primary completion
May 1, 2024
Completion
May 1, 2024
Last update posted
May 19, 2025

2022 – 2024

United States locations

U.S. sites
71
U.S. states
28
U.S. cities
68
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209
Research Site Huntsville Alabama 35805
Research Site Beverly Hills California 90211
Research Site Chula Vista California 91910
Research Site Fountain Valley California 92708
Research Site Granada Hills California 91344
Research Site Lancaster California 93534
Research Site Lincoln California 95648
Research Site Los Angeles California 90010
Research Site Lynwood California 90262
Research Site Northridge California 91324
Research Site Panorama City California 91402
Research Site Pomona California 91767
Research Site Rancho Cucamonga California 91730
Research Site Riverside California 92503
Research Site San Dimas California 91773
Research Site South Gate California 90280
Research Site Tarzana California 91356
Research Site Vacaville California 95687
Research Site Victorville California 92392
Research Site Arvada Colorado 80002
Research Site Littleton Colorado 80120
Research Site Hollywood Florida 33021
Research Site Orlando Florida 32807
Research Site Orlando Florida 32808
Research Site Tampa Florida 33612
Research Site West Palm Beach Florida 33401
Research Site Columbus Georgia 31904
Research Site Decatur Georgia 30030
Research Site Nampa Idaho 83687
Research Site Chicago Illinois 60643
Research Site Brownsburg Indiana 46112
Research Site Lexington Kentucky 40503
Research Site Metairie Louisiana 70006
Research Site Monroe Louisiana 71201
Research Site Silver Spring Maryland 20904
Research Site New Bedford Massachusetts 02740
Research Site Flint Michigan 48504
Research Site Flint Michigan 48532
Research Site Troy Michigan 48085
Research Site Olive Branch Mississippi 38654
Research Site Kansas City Missouri 64111
Research Site Trenton New Jersey 08611
Research Site The Bronx New York 10455
Research Site Durham North Carolina 27704
Research Site Greenville North Carolina 27834
Research Site Kinston North Carolina 28504
Research Site Morganton North Carolina 28655
Research Site Oxford North Carolina 27565
Research Site Wilmington North Carolina 28401
Research Site Cincinnati Ohio 45246
Research Site Bethany Oklahoma 73008
Research Site Scottdale Pennsylvania 15683
Research Site Smithfield Pennsylvania 15478
Research Site Providence Rhode Island 02903
Research Site Memphis Tennessee 38119
Research Site Houston Texas 77099
Research Site Lampasas Texas 76550
Research Site Paris Texas 75462
Research Site Red Oak Texas 75154
Research Site San Antonio Texas 78212
Research Site San Antonio Texas 78249
Research Site Salt Lake City Utah 84132
Research Site Burlington Vermont 05401
Research Site Alexandria Virginia 22304
Research Site Burke Virginia 22015
Research Site Charlottesville Virginia 22908
Research Site Manassas Virginia 20110
Research Site Newport News Virginia 23606
Research Site Salem Virginia 24153
Research Site Kingwood West Virginia 26537

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05432167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2025 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05432167 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →